MICIACCIA, MORENA
 Distribuzione geografica
Continente #
NA - Nord America 354
EU - Europa 178
AS - Asia 39
OC - Oceania 1
Totale 572
Nazione #
US - Stati Uniti d'America 349
IT - Italia 103
SE - Svezia 42
CN - Cina 20
BE - Belgio 14
GB - Regno Unito 10
JP - Giappone 7
CA - Canada 5
IN - India 5
HU - Ungheria 4
IL - Israele 2
SG - Singapore 2
AU - Australia 1
BG - Bulgaria 1
EE - Estonia 1
FR - Francia 1
IE - Irlanda 1
IR - Iran 1
KR - Corea 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 572
Città #
Chandler 48
Nyköping 39
Sannicandro di Bari 39
Fairfield 37
Ashburn 34
Bari 29
Cambridge 17
Woodbridge 16
Brussels 14
Houston 13
Seattle 13
Wilmington 10
Beijing 9
New York 8
Ann Arbor 6
Lawrence 6
Tokyo 6
Bitonto 5
Dearborn 5
Roxbury 5
Des Moines 4
Kornye 4
Milan 4
Valenzano 4
Valparaiso 4
Wallsend 4
Inglewood 3
Nanjing 3
Racale 3
Toronto 3
Alexandria 2
Bedford 2
Coimbatore 2
Hemel Hempstead 2
Irving 2
Minneapolis 2
Port Clinton 2
Rome 2
San Diego 2
San Francisco 2
Santa Marinella 2
Saskatoon 2
Stanford 2
Tel Aviv 2
Virginia Beach 2
Adelfia 1
Altoona 1
Ardabil 1
Bloomington 1
Brisbane 1
Brooklyn 1
Changsha 1
Fort Worth 1
Harbin 1
Hebei 1
Hefei 1
Hounslow 1
Jiaxing 1
Livermore 1
Monmouth Junction 1
Multan 1
Musashino 1
Nanchang 1
Paris 1
Prescot 1
Princeton 1
Prineville 1
Pune 1
Redmond 1
Redwood City 1
San Mateo 1
Sofia 1
Tallinn 1
Triggiano 1
Wexford 1
Totale 455
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 124
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection 110
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment 82
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid 50
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders 44
Neuroinflammation and Microglial Constitutive COX-1 Inhibition 38
Three-dimensional structure of human cyclooxygenase (hCOX)-1 34
Ovine COX-1 Isoenzyme Bio-production 33
Patient Bone Marrow Aspiration to Explore the Cyclooxygenases (COXs) Involvement in Multiple Myeloma 15
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes 12
Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design 12
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG) 9
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel mediated resistance in gastric cancer cell lines 9
Olive Mill Wastewater Fermented with Microbial Pools as a New Potential Functional Beverage 9
A Simplified Direct O2 Consumption-Based Assay to Test COX Inhibition 9
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19 7
m-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective Activity 7
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer 7
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER 7
MODULATORS OF HUMAN MITOCHONDRIAL PROTEASE ClpP ACTIVITY FOR PEDIATRIC DIFFUSE PONTINE GLIOMA TREATMENT 6
Comparative Structural Analysis of hCOX‑1 and oCOX‑1 Isoenzymes 6
Human Caseinolytic Protease P (hClpP) Activity Modulating Agents For The Treatment Of DIPG/DMG 5
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 5
Inside circular economy challenges: “green” application to valorise olive mill wastewater 4
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment 2
Totale 646
Categoria #
all - tutte 3.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 1 3 0 0
2019/202096 10 5 4 10 7 7 7 7 9 17 9 4
2020/202187 7 4 0 8 10 8 0 8 16 15 7 4
2021/202275 10 6 1 2 2 5 2 14 3 8 9 13
2022/2023155 8 19 17 6 18 21 4 28 20 4 6 4
2023/2024228 4 15 16 24 31 18 16 8 96 0 0 0
Totale 646